AstraZeneca today announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. This investment will leverage the ...
First patients dosed in DAYBreak™ registrational program for bexobrutideg in relapsed/refractory CLLPresented Phase 1 results at ASH 2025 that ...
Q4 2025 Earnings Call January 29, 2026 8:30 AM EST Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2025 Fourth Quarter Conference Call. [Operator Instructions] I would ...
The California Medical Association, one of the most active players in state politics, is endorsing Rep. Eric Swalwell in the ...
Researchers are continually looking for new ways to hack the cellular machinery of microbes like yeast and bacteria to make ...
Your organs are constantly talking to each other in ways we’re only beginning to understand. Tapping into these communication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results